AMZN vs ELAB · P/E 31, rev $716.92B vs rev $2.0M
Amazon.com Inc (AMZN) versus Elevai Labs, Inc. Common Stock (ELAB) — a side-by-side from cached financials, not a winner call.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
AMZN currently screens at market cap $2.55T and trailing P/E 30.6. ELAB currently screens at market cap $6.5M.
Not investment advice. Open the AMZN and ELAB stock pages for the full models.
Not investment advice.